{"id":303,"date":"2021-01-24T08:19:11","date_gmt":"2021-01-24T08:19:11","guid":{"rendered":"https:\/\/www.snijderlab.org\/news\/?p=303"},"modified":"2021-01-25T15:47:16","modified_gmt":"2021-01-25T15:47:16","slug":"introducing-the-tumor-profiler-study","status":"publish","type":"post","link":"https:\/\/www.snijderlab.org\/news\/2021\/01\/24\/introducing-the-tumor-profiler-study\/","title":{"rendered":"Introducing the Tumor Profiler"},"content":{"rendered":"\n<p>The introduction to our large collaborative effort between ETH Z\u00fcrich, University Hospitals in Z\u00fcrich and Basel, University of Z\u00fcrich, and Roche just came out in <a rel=\"noreferrer noopener\" href=\"https:\/\/www.cell.com\/cancer-cell\/fulltext\/S1535-6108(21)00048-9\" target=\"_blank\">Cancer Cell<\/a>! An accompanying ETH News item on the topic is available <a rel=\"noreferrer noopener\" href=\"https:\/\/ethz.ch\/en\/news-and-events\/eth-news\/news\/2021\/01\/detailed-tumour-profiling.html\" target=\"_blank\">here<\/a>. And the highly read Blick.ch newspaper also reported on the article (in German): &#8220;<a rel=\"noreferrer noopener\" href=\"https:\/\/www.blick.ch\/schweiz\/krebs-individualisierte-krebstherapien-dank-tumor-profiling-in-griffweite-id16306004.html\" target=\"_blank\">Individualisierte Krebstherapien dank Tumor Profiling in Griffweite<\/a>&#8220;. <\/p>\n\n\n\n<figure class=\"wp-block-gallery columns-1 is-cropped wp-block-gallery-1 is-layout-flex wp-block-gallery-is-layout-flex\"><ul class=\"blocks-gallery-grid\"><li class=\"blocks-gallery-item\"><figure><a href=\"https:\/\/www.snijderlab.org\/news\/wp-content\/uploads\/2021\/01\/210125_Blick_TuPro_Screenshot-1.png\"><img loading=\"lazy\" decoding=\"async\" width=\"2407\" height=\"644\" src=\"https:\/\/www.snijderlab.org\/news\/wp-content\/uploads\/2021\/01\/210125_Blick_TuPro_Screenshot-1.png\" alt=\"Tumor Profiler in Blick.ch\" data-id=\"314\" class=\"wp-image-314\" srcset=\"https:\/\/www.snijderlab.org\/news\/wp-content\/uploads\/2021\/01\/210125_Blick_TuPro_Screenshot-1.png 2407w, https:\/\/www.snijderlab.org\/news\/wp-content\/uploads\/2021\/01\/210125_Blick_TuPro_Screenshot-1-300x80.png 300w, https:\/\/www.snijderlab.org\/news\/wp-content\/uploads\/2021\/01\/210125_Blick_TuPro_Screenshot-1-1024x274.png 1024w, https:\/\/www.snijderlab.org\/news\/wp-content\/uploads\/2021\/01\/210125_Blick_TuPro_Screenshot-1-768x205.png 768w, https:\/\/www.snijderlab.org\/news\/wp-content\/uploads\/2021\/01\/210125_Blick_TuPro_Screenshot-1-1536x411.png 1536w, https:\/\/www.snijderlab.org\/news\/wp-content\/uploads\/2021\/01\/210125_Blick_TuPro_Screenshot-1-2048x548.png 2048w\" sizes=\"auto, (max-width: 2407px) 100vw, 2407px\" \/><\/a><\/figure><\/li><\/ul><\/figure>\n\n\n\n<p>The Tumor Profiler integrates 9 different methodologies, including <a href=\"https:\/\/www.snijderlab.org\/#pharmacoscopy\" data-type=\"URL\" data-id=\"https:\/\/www.snijderlab.org\/#pharmacoscopy\">Pharmacoscopy<\/a>, to generate an in-depth characterisation of melanoma, leukaemia and ovarian cancer tumors. This characterisation aims to support clinical treatment decisions and improve the biological understanding of these cancers.<\/p>\n\n\n\n<figure class=\"wp-block-embed-twitter wp-block-embed is-type-rich is-provider-twitter\"><div class=\"wp-block-embed__wrapper\">\n<blockquote class=\"twitter-tweet\" data-width=\"550\" data-dnt=\"true\"><p lang=\"en\" dir=\"ltr\">Great to finally see the <a href=\"https:\/\/twitter.com\/hashtag\/TumorProfiler?src=hash&amp;ref_src=twsrc%5Etfw\">#TumorProfiler<\/a> consortium announced in <a href=\"https:\/\/twitter.com\/Cancer_Cell?ref_src=twsrc%5Etfw\">@Cancer_Cell<\/a>! Awesome teamwork between <a href=\"https:\/\/twitter.com\/Roche?ref_src=twsrc%5Etfw\">@Roche<\/a> <a href=\"https:\/\/twitter.com\/ETH?ref_src=twsrc%5Etfw\">@ETH<\/a> <a href=\"https:\/\/twitter.com\/IMSB_ETH?ref_src=twsrc%5Etfw\">@IMSB_ETH<\/a> <a href=\"https:\/\/twitter.com\/UZH_en?ref_src=twsrc%5Etfw\">@UZH_en<\/a>  <a href=\"https:\/\/twitter.com\/Unispital_USZ?ref_src=twsrc%5Etfw\">@Unispital_USZ<\/a> <a href=\"https:\/\/twitter.com\/UniSpitalBasel?ref_src=twsrc%5Etfw\">@UniSpitalBasel<\/a> to advance <a href=\"https:\/\/twitter.com\/hashtag\/PrecisionMedicine?src=hash&amp;ref_src=twsrc%5Etfw\">#PrecisionMedicine<\/a> of <a href=\"https:\/\/twitter.com\/hashtag\/melanoma?src=hash&amp;ref_src=twsrc%5Etfw\">#melanoma<\/a>, <a href=\"https:\/\/twitter.com\/hashtag\/ovariancancer?src=hash&amp;ref_src=twsrc%5Etfw\">#ovariancancer<\/a> and <a href=\"https:\/\/twitter.com\/hashtag\/leukemia?src=hash&amp;ref_src=twsrc%5Etfw\">#leukemia<\/a> <a href=\"https:\/\/t.co\/owIN6EhEIZ\">https:\/\/t.co\/owIN6EhEIZ<\/a><\/p>&mdash; Berend Snijder (@BerendSnijder) <a href=\"https:\/\/twitter.com\/BerendSnijder\/status\/1352540022617075712?ref_src=twsrc%5Etfw\">January 22, 2021<\/a><\/blockquote><script async src=\"https:\/\/platform.twitter.com\/widgets.js\" charset=\"utf-8\"><\/script>\n<\/div><\/figure>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The introduction to our large collaborative effort between ETH Z\u00fcrich, University Hospitals in Z\u00fcrich and Basel, University of Z\u00fcrich, and Roche just came out in Cancer Cell! An accompanying ETH News item on the topic is available here. And the highly read Blick.ch newspaper also reported on the article (in German): &#8220;Individualisierte Krebstherapien dank Tumor&hellip; <a class=\"more-link\" href=\"https:\/\/www.snijderlab.org\/news\/2021\/01\/24\/introducing-the-tumor-profiler-study\/\">Continue reading <span class=\"screen-reader-text\">Introducing the Tumor Profiler<\/span> <span class=\"meta-nav\" aria-hidden=\"true\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1,5],"tags":[],"class_list":["post-303","post","type-post","status-publish","format-standard","hentry","category-news","category-publications"],"_links":{"self":[{"href":"https:\/\/www.snijderlab.org\/news\/wp-json\/wp\/v2\/posts\/303","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.snijderlab.org\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.snijderlab.org\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.snijderlab.org\/news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.snijderlab.org\/news\/wp-json\/wp\/v2\/comments?post=303"}],"version-history":[{"count":9,"href":"https:\/\/www.snijderlab.org\/news\/wp-json\/wp\/v2\/posts\/303\/revisions"}],"predecessor-version":[{"id":318,"href":"https:\/\/www.snijderlab.org\/news\/wp-json\/wp\/v2\/posts\/303\/revisions\/318"}],"wp:attachment":[{"href":"https:\/\/www.snijderlab.org\/news\/wp-json\/wp\/v2\/media?parent=303"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.snijderlab.org\/news\/wp-json\/wp\/v2\/categories?post=303"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.snijderlab.org\/news\/wp-json\/wp\/v2\/tags?post=303"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}